We use cookies to improve our services and to provide you with tailored content for an improved experience. By clicking "Accept", you consent to cookies.
Shawn dives into the pressing issue of how compounded medications can and should be marketed — and how both transparency and regulatory practices play essential roles in that marketing. (Not only was Shawn included, he's the only compounding pharmacy executive named in the article.)
Shawn is just one of the amazing team members at Revelation Pharma, which isn't surprising — Revelation is officially a Great Place
Erectile Dysfunction is an extremely common disorder among men worldwide. So much so that it is estimated that 322 million men will be afflicted by the year 2025. Men experience increased symptoms of ED as they age by 10% per decade of life and researchers are seeing onset of symptoms in younger men due to changes in lifestyle like higher rates of obesity and alcohol or substance abuse. Other factors that contribute to erectile dysfunction are conditions related to vascular disease that impede circulatory function, neurological conditions, physiological and hormonal issues, surgeries, injuries, and mental health conditions or side effects caused by the medication used
Healthcare practitioners often encounter patients presenting with vaginal discomfort and discharge. Two common culprits behind these symptoms are bacterial vaginosis (BV) and yeast infections (candidiasis). Although these conditions share similar symptoms, their etiologies, treatments, and implications can vary significantly.
Understanding bacterial vaginosis
Bacterial vaginosis is an imbalance of the vaginal flora. It occurs when an overgrowth of anaerobic bacteria, including Gardnerella vaginalis, overwhelms the beneficial lactobacilli. BV is the most common vaginal infection in women of reproductive age.
Check it out! Our friends at the National Association of Nurse Practitioners in Women’s Health’s (NPWH) have just dropped the inaugural episode of their “Her Health Matters” podcast — available wherever you get your podcasts.
In that first episode, host Heather Maurer chats with Dr. Komkwuan Paruchabutr, president of NPWH’s board of directors about Dr. Paruchabutr’s journey to becoming a Women's Health Nurse Practitioner, and what makes WHNPs so critical. They also discuss the important changes — personal and systemic — that need to be made to advance women’s and gender-related health care.
At Revelation Pharma we appreciate NPWH’s message so much, we’ve sponsored that first episode. Listen